Median Technologies to Host Two Webcasts, and Provide a Company Update on January 30, 2024

Regulatory News:

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on January 30, 2024:

• Webcast held in English: at 4:30 pm CET / 10:30 am ET
  ➨ Registration link
  

• Webcast held in French: at 6:00 pm CET / 12:00 pm ET
  ➨ Registration link

Webcast replays will be available on Median’s corporate website after the live sessions.

About Median Technologies: Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer and metabolic disease diagnoses and treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. Since its inception, the French-based company, with a presence in the U.S. and China, has been recognized as an "Innovative company" by BPI France and trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240125989634/en/

The Median Technologies Stock at the time of publication of the news with a fall of -0,84 % to 3,82EUR on Lang & Schwarz stock exchange (25. Januar 2024, 17:43 Uhr).